Ocean Biomedical, Inc.
OCEA
$0.0061
-$0.0006-8.96%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -46.38% | 128.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -45.35% | 128.26% | |||
| Operating Income | 45.35% | -128.26% | |||
| Income Before Tax | -3,011.66% | 105.12% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3,011.66% | 105.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3,011.66% | 105.12% | |||
| EBIT | 45.35% | -128.26% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -987.25% | 105.07% | |||
| Normalized Basic EPS | -984.38% | 105.09% | |||
| EPS Diluted | -987.25% | 105.07% | |||
| Normalized Diluted EPS | -984.38% | 105.09% | |||
| Average Basic Shares Outstanding | 228.97% | 0.66% | |||
| Average Diluted Shares Outstanding | 228.97% | 0.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||